title: Androgen inducibility of Fgf8 in Shionogi carcinoma 115 cells correlates with an adjacent t(5;19) translocation.
abstract: Fgf8 (fibroblast growth factor 8) was initially cloned from a mouse mammary tumor cell line derived from the androgen-dependent Shionogi carcinoma 115. The androgen-inducible expression of Fgf8 in this tumor controls its androgen-dependent phenotype, thus stimulating interest in this gene as a possible factor in human prostate cancer and other androgen-sensitive cancers. However, apart from Shionogi carcinoma 115, the androgen inducibility of Fgf8 is controversial. In the present study, having not detected androgen-inducible expression of Fgf8 in other mouse mammary cell lines or mouse prostate, we examined the Shionogi carcinoma 115-derived S115 cell line for mouse mammary tumor virus (MMTV) insertions or other nearby DNA rearrangements that might explain the androgen inducibility of Fgf8 in these cells. Southern blotting did not detect MMTV insertions near Fgf8 but did reveal a specific DNA rearrangement 3.7 kb upstream of Fgf8 in S115 cells and in other cells (SC115) independently derived from Shionogi carcinoma 115. Spectral karyotyping of S115 cells and sequencing of the cloned rearrangement junctions indicate that Fgf8 is involved in a t(5;19) translocation. The chromosome 5 sequence joined to Fgf8 is immediately adjacent to Smr2 (submaxillary gland androgen-regulated protein 2) and includes Muc10 (mucin 10), two genes that we show are testosterone inducible in S115 cells, suggesting that the androgen-dependent expression of Fgf8 in Shionogi carcinoma 115 and derivative cells results from this translocation. Together, these results suggest that androgen inducibility is not an inherent property of the Fgf8 gene, which has implications regarding this gene's proposed role in the etiology of hormone-responsive cancers.
authors.affiliation: Division of Hematology-Oncology, The Saban Research Institute, Childrens Hospital Los Angeles, California, USA.
authors.forename: Anat
authors.initials: A
authors.lastname: Erdreich-Epstein
authors.forename: Amit K
authors.initials: AK
authors.lastname: Ganguly
authors.forename: Xiang-He
authors.initials: XH
authors.lastname: Shi
authors.forename: Drazen B
authors.initials: DB
authors.lastname: Zimonjic
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Shackleford
mesh_terms: D000728:Androgens / Q000502:physiology*; D001483:Base Sequence; D015139:Blotting, Southern; D045744:Cell Line, Tumor; D002888:Chromosomes, Human, Pair 19; D002895:Chromosomes, Human, Pair 5; D004273:DNA, Neoplasm; D051524:Fibroblast Growth Factor 8 / Q000235:genetics*; D006801:Humans; D007621:Karyotyping; D008297:Male; D008324:Mammary Tumor Virus, Mouse / Q000235:genetics; D008969:Molecular Sequence Data; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012689:Sequence Homology, Nucleic Acid; D014178:Translocation, Genetic
chemical_list: D000728:Androgens; D004273:DNA, Neoplasm; C496456:FGF8 protein, human; D051524:Fibroblast Growth Factor 8